Traders bought shares of Colgate-Palmolive Company (NYSE:CL) on weakness during trading hours on Monday. $38.77 million flowed into the stock on the tick-up and $19.97 million flowed out of the stock on the tick-down, for a money net flow of $18.80 million into the stock. Of all equities tracked, Colgate-Palmolive had the 21st highest net in-flow for the day. Colgate-Palmolive traded down ($0.34) for the day and closed at $71.30

A number of equities research analysts have issued reports on CL shares. Bank of America Corporation boosted their target price on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, May 31st. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Jefferies Group LLC reissued a “hold” rating and set a $79.00 target price on shares of Colgate-Palmolive in a report on Thursday, August 24th. Vetr cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price on the stock. in a report on Wednesday, May 17th. Finally, Royal Bank Of Canada reissued a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a report on Thursday, May 25th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have assigned a buy rating to the company’s stock. Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $75.82.

The stock has a market capitalization of $62.64 billion, a PE ratio of 26.43 and a beta of 0.80. The company’s 50-day moving average price is $71.72 and its 200-day moving average price is $73.37.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. The company had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. Colgate-Palmolive’s quarterly revenue was down .5% on a year-over-year basis. During the same period last year, the company posted $0.70 earnings per share. Equities research analysts anticipate that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, August 15th. Investors of record on Tuesday, July 18th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, July 14th. This represents a $1.60 annualized dividend and a yield of 2.25%. Colgate-Palmolive’s payout ratio is 59.48%.

In related news, CFO Dennis J. Hickey sold 73,872 shares of the firm’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $71.80, for a total transaction of $5,304,009.60. Following the completion of the transaction, the chief financial officer now directly owns 484,985 shares of the company’s stock, valued at $34,821,923. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $75.67, for a total transaction of $290,043.11. Following the transaction, the insider now directly owns 53,022 shares of the company’s stock, valued at $4,012,174.74. The disclosure for this sale can be found here. Insiders have sold 221,802 shares of company stock valued at $15,983,976 over the last ninety days. 1.02% of the stock is currently owned by corporate insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Blue Chip Partners Inc. grew its stake in Colgate-Palmolive by 0.4% during the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock valued at $132,000 after acquiring an additional 8 shares in the last quarter. Cue Financial Group Inc. grew its stake in Colgate-Palmolive by 0.3% during the second quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock valued at $360,000 after acquiring an additional 14 shares in the last quarter. Cornerstone Financial Partners LLC grew its stake in Colgate-Palmolive by 0.5% during the second quarter. Cornerstone Financial Partners LLC now owns 3,813 shares of the company’s stock valued at $282,000 after acquiring an additional 19 shares in the last quarter. M Holdings Securities Inc. grew its stake in Colgate-Palmolive by 0.4% during the first quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock valued at $393,000 after acquiring an additional 21 shares in the last quarter. Finally, AlphaMark Advisors LLC grew its stake in Colgate-Palmolive by 1.5% during the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after acquiring an additional 25 shares in the last quarter. 73.16% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This story was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.dailypolitical.com/2017/09/06/traders-buy-colgate-palmolive-company-cl-on-weakness-4.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.